Literature DB >> 24837758

Binge drinking, stimulant use and HIV risk in a sample of illicit drug using heterosexual Black men.

Larry Keen1, Typhanye Penniman Dyer2, Nicole Ennis Whitehead1, William Latimer1.   

Abstract

BACKGROUND: Relatively little research has examined the effects of binge drinking and HIV risk in heterosexual Black men. Even less research has explored this relationship in illicit drug using heterosexual Black men who are at an elevated risk of contracting and transmitting HIV through various vectors, including risky sexual behavior, in the Black community.
PURPOSE: The purpose of the current study is to examine the associations between binge drinking, drug use and HIV status in a community-based sample of 127 self-identified heterosexual Black men.
RESULTS: Overall, 17% reported binge drinking in the past month. Both stimulant use (AOR 7.29; 95%; CIs, 2.07, 25.70), and binge drinking (AOR=5.28; 95% CIs, 1.34, 20.91) were associated with HIV status.
CONCLUSION: These findings will inform prevention interventions to reduce the HIV risk among Black heterosexual men.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Binge drinking; Black; Drug use; HIV; Heterosexual; Men

Mesh:

Substances:

Year:  2014        PMID: 24837758      PMCID: PMC4090766          DOI: 10.1016/j.addbeh.2014.04.006

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  22 in total

1.  Heterosexual transmission of human immunodeficiency virus among intravenous drug users.

Authors:  R J Battjes; R W Pickens; Z Amsel; L S Brown
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Understanding the HIV risk reduction needs of heterosexual African American substance-abusing men.

Authors:  Julie A Cederbaum; Christopher Lance Coleman; Gretchen Goller; Loretta Sweet Jemmott
Journal:  J Assoc Nurses AIDS Care       Date:  2006 Nov-Dec       Impact factor: 1.354

3.  Younger versus older African Americans: patterns and prevalence of recent illicit drug use.

Authors:  Nicole Ennis Whitehead; Rebecca C Trenz; Larry Keen; Jonathan Rose; William W Latimer
Journal:  J Ethn Subst Abuse       Date:  2014       Impact factor: 1.507

Review 4.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.

Authors:  Bradley M Mathers; Louisa Degenhardt; Benjamin Phillips; Lucas Wiessing; Matthew Hickman; Steffanie A Strathdee; Alex Wodak; Samiran Panda; Mark Tyndall; Abdalla Toufik; Richard P Mattick
Journal:  Lancet       Date:  2008-09-23       Impact factor: 79.321

5.  HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual.

Authors:  Amy Rock Wohl; Denise F Johnson; Sharon Lu; Wilbert Jordan; Gildon Beall; Judith Currier; Paul A Simon
Journal:  J Acquir Immune Defic Syndr       Date:  2002-11-01       Impact factor: 3.731

6.  HIV, heroin and heterosexual relations.

Authors:  S Kane
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

7.  Male heterosexual crack smokers with multiple sex partners: between- and within-person predictors of condom use intention.

Authors:  Anne Bowen; Mark Williams; Eric Dearing; Sandra Timpson; Michael Ross
Journal:  Health Educ Res       Date:  2006-05-04

8.  Racial disparities in sexual risk behaviors and drug use among older gay/bisexual and heterosexual men living with HIV/AIDS.

Authors:  Karolynn Siegel; Eric W Schrimshaw; Daniel Karus
Journal:  J Natl Med Assoc       Date:  2004-02       Impact factor: 1.798

9.  Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection.

Authors:  Adaora A Adimora; Victor J Schoenbach; Francis E A Martinson; Kathryn H Donaldson; Tonya R Stancil; Robert E Fullilove
Journal:  J Acquir Immune Defic Syndr       Date:  2003-12-01       Impact factor: 3.731

10.  HIV risk behaviors among rural stimulant users: variation by gender and race/ethnicity.

Authors:  Patricia B Wright; Katharine E Stewart; Ellen P Fischer; Robert G Carlson; Russel Falck; Jichuan Wang; Carl G Leukefeld; Brenda M Booth
Journal:  AIDS Educ Prev       Date:  2007-04
View more
  1 in total

1.  Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention.

Authors:  Arame Thiam-Diouf; Barbara Metch; Cameron Sharpe; Robel Mulugeta; Michele Peake Andrasik
Journal:  Vaccine       Date:  2018-02-21       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.